SUPN logo

Supernus Pharmaceuticals (SUPN) Long term liabilities

Annual long term liabilities:

$39.94M-$26.02M(-39.44%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual total long term liabilities is $39.94 million, with the most recent change of -$26.02 million (-39.44%) on December 31, 2024.
  • During the last 3 years, SUPN annual long term liabilities has fallen by -$517.98 million (-92.84%).
  • SUPN annual long term liabilities is now -92.84% below its all-time high of $557.92 million, reached on December 31, 2021.

Performance

SUPN Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly long term liabilities:

$34.81M-$5.13M(-12.84%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly total long term liabilities is $34.81 million, with the most recent change of -$5.13 million (-12.84%) on March 31, 2025.
  • Over the past year, SUPN quarterly long term liabilities has dropped by -$25.56 million (-42.33%).
  • SUPN quarterly long term liabilities is now -93.76% below its all-time high of $557.92 million, reached on December 31, 2021.

Performance

SUPN quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

SUPN Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.4%-42.3%
3 y3 years-92.8%-93.4%
5 y5 years-90.1%-91.5%

SUPN Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.8%at low-93.4%at low
5 y5-year-92.8%at low-93.8%at low
alltimeall time-92.8%+197.3%-93.8%+222.9%

SUPN Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$34.81M(-12.8%)
Dec 2024
$39.94M(-39.4%)
$39.94M(-9.3%)
Sep 2024
-
$44.04M(-11.4%)
Jun 2024
-
$49.72M(-17.6%)
Mar 2024
-
$60.37M(-8.5%)
Dec 2023
$65.96M(-48.6%)
$65.96M(-22.8%)
Sep 2023
-
$85.44M(-29.2%)
Jun 2023
-
$120.60M(-18.6%)
Mar 2023
-
$148.11M(+15.4%)
Dec 2022
$128.35M(-77.0%)
$128.35M(+12.2%)
Sep 2022
-
$114.34M(-3.1%)
Jun 2022
-
$118.00M(-77.6%)
Mar 2022
-
$526.51M(-5.6%)
Dec 2021
$557.92M(+8.5%)
$557.92M(+9.4%)
Sep 2021
-
$509.86M(+1.2%)
Jun 2021
-
$504.03M(-1.6%)
Mar 2021
-
$512.19M(-0.4%)
Dec 2020
$514.14M(+27.2%)
$514.14M(+2.5%)
Sep 2020
-
$501.54M(-9.8%)
Jun 2020
-
$555.77M(+36.2%)
Mar 2020
-
$408.15M(+1.0%)
Dec 2019
$404.27M(+11.2%)
$404.27M(+1.1%)
Sep 2019
-
$399.94M(+0.8%)
Jun 2019
-
$396.80M(+0.8%)
Mar 2019
-
$393.72M(+8.3%)
Dec 2018
$363.44M(+969.4%)
$363.44M(+0.3%)
Sep 2018
-
$362.23M(+1.1%)
Jun 2018
-
$358.37M(+1.2%)
Mar 2018
-
$354.20M(+942.3%)
DateAnnualQuarterly
Dec 2017
$33.98M(-8.3%)
$33.98M(+17.8%)
Sep 2017
-
$28.86M(-8.2%)
Jun 2017
-
$31.45M(-8.0%)
Mar 2017
-
$34.19M(-7.8%)
Dec 2016
$37.07M(-15.1%)
$37.07M(-7.5%)
Sep 2016
-
$40.10M(+233.1%)
Jun 2016
-
$12.04M(-1.4%)
Mar 2016
-
$12.21M(-72.0%)
Dec 2015
$43.69M(-35.7%)
$43.69M(+207.5%)
Sep 2015
-
$14.21M(-7.7%)
Jun 2015
-
$15.39M(-15.4%)
Mar 2015
-
$18.20M(-73.2%)
Dec 2014
$67.96M(+32.9%)
$67.96M(+78.5%)
Sep 2014
-
$38.08M(-8.5%)
Jun 2014
-
$41.63M(+0.6%)
Mar 2014
-
$41.41M(-19.0%)
Dec 2013
$51.13M(+280.6%)
$51.13M(-40.7%)
Sep 2013
-
$86.24M(+7.7%)
Jun 2013
-
$80.06M(+642.6%)
Mar 2013
-
$10.78M(-19.8%)
Dec 2012
$13.44M(-47.3%)
$13.44M(-24.5%)
Sep 2012
-
$17.79M(-11.5%)
Jun 2012
-
$20.10M(-12.7%)
Mar 2012
-
$23.02M(-9.8%)
Dec 2011
$25.52M(-66.5%)
$25.52M(-71.1%)
Sep 2011
-
$88.32M(+16.0%)
Dec 2010
$76.12M(+0.1%)
$76.12M(+0.1%)
Sep 2010
-
$76.01M(-0.0%)
Dec 2009
$76.02M(+0.5%)
$76.02M
Dec 2008
$75.61M
-

FAQ

  • What is Supernus Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual long term liabilities for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual long term liabilities year-on-year change?
  • What is Supernus Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Supernus Pharmaceuticals annual total long term liabilities?

The current annual long term liabilities of SUPN is $39.94M

What is the all time high annual long term liabilities for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual total long term liabilities is $557.92M

What is Supernus Pharmaceuticals annual long term liabilities year-on-year change?

Over the past year, SUPN annual total long term liabilities has changed by -$26.02M (-39.44%)

What is Supernus Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of SUPN is $34.81M

What is the all time high quarterly long term liabilities for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly total long term liabilities is $557.92M

What is Supernus Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, SUPN quarterly total long term liabilities has changed by -$25.56M (-42.33%)
On this page